References
- PolanczykGde LimaMSHortaBLBiedermanJRohdeLAThe worldwide prevalence of ADHD: a systematic review and metaregression analysisAm J Psychiatry200716494294817541055
- American Psychiatric AssociationAttention-deficit and disruptive behavior disordersDiagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, Fourth Edition Text RevisionWashington, DCAmerican Psychiatric Association20008593
- PliszkaSAACAP Work Group on Quality IssuesPractice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry20074689492117581453
- PennickMAbsorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamineNeuropsychiatr Dis Treat2010631732720628632
- BiedermanJBoellnerSWChildressALopezFAKrishnanSZhangYLisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom studyBiol Psychiatry20076297097617631866
- BiedermanJKrishnanSZhangYMcGoughJJFindlingRLEfficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group studyClin Ther20072945046317577466
- LopezFAGinsbergLDArnoldVEffect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: a secondary analysisPostgrad Med20081208910218824828
- WigalSBKollinsSHChildressACSquiresL311 Study GroupA 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderChild Adolesc Psychiatry Ment Health200931719508731
- GuyWClinical global impressionsECDEU Assessment Manual for PsychopharmacologyRockville, MDUS Department of Health, Education, and Welfare; Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch1976218222
- LópezFAChildressACCurtissSImprovement in attention-deficit/hyperactivity disorder symptoms in children with lisdexamfetamine dimesylate versus extended-release mixed amphetamine salts and placebo in an analog classroomPoster presented at: American College of Clinical Pharmacy Annual Meeting1019–222008Louisville, KY
- GoodmanDWLisdexamfetamine dimesylate (Vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorderP T20103527328720514273
- Vyvanse [package insert]Wayne, PAShire US Inc2010
- McGoughJJBiedermanJGreenhillLLPharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of AdderallJ Am Acad Child Adolesc Psychiatry20034268469112921476
- Adderall XR [package insert]Wayne, PAShire US Inc2010
- GoodmanDFaraoneSVAdlerLADirksBHamdaniMWeislerRInterpreting ADHD rating scale scores: linking ADHD rating scale scores and CGI levels in two randomized controlled trials of lisdexamfetamine dimesylate in ADHDPrimary Psychiatry2010174452
- WilliamsJBWMental health status, functioning and disabilities measuresRushAJJrFirstMBBlackerDHandbook of Psychiatric Measures2nd edWashington, DCAmerican Psychiatric Publishing, Inc2008